SCHEMBL5091091

SCHEMBL5091091

CN1CCCN(c2ccc3cnn(S(=O)(=O)c4ccc5ccoc5c4)c3c2)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP9X Q93008 1/20 0.47
HTR6 P50406 8/20 0.41
HTR1A P08908 4/20 0.41
DRD2 P14416 2/20 0.41
HTR2A P28223 3/20 0.40
HTR2C P28335 3/20 0.40
DRD3 P35462 3/20 0.40
HTR7 P34969 2/20 0.40
DRD4 P21917 1/20 0.40
AKT1 P31749 1/20 0.38
PIK3CA P42336 1/20 0.38
PKM P14618 1/20 0.38
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
ALDH1A1 P00352 1/20 0.37
MAPK1 P28482 1/20 0.37
ADORA2A P29274 1/20 0.36
ADORA1 P30542 1/20 0.36
CHRM1 P11229 1/20 0.36
RAD52 P43351 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5103393 0.94 CHRM1 (0.43) USP9XHTR6HTR1ADRD2HTR2A
SCHEMBL5097203 0.85 HTR6 (0.40) USP9XHTR6AKT1PIK3CAALDH1A1
SCHEMBL5097156 0.80 PKM (0.42) USP9XHTR6HTR1ADRD2HTR2A
SCHEMBL5103843 0.79 CHRM1 (0.41) USP9XHTR6PKMALDH1A1CHRM1
SCHEMBL5103502 0.76 GBA1 (0.44) USP9XHTR6HTR1ADRD2HTR2A
SCHEMBL5091053 0.75 HTR6 (0.41) HTR6HTR1ADRD2HTR2AHTR2C
SCHEMBL5103499 0.75 HTR6 (0.51) HTR6HTR1ADRD2HTR2CDRD3
SCHEMBL5097192 0.73 RXFP1 (0.45) HTR6HTR1ADRD2HTR2ADRD3
SCHEMBL5097197 0.73 TNF (0.56) MAPK1
SCHEMBL8680901 0.71 HDAC3 (0.48) HTR6HTR1ADRD2HTR2AHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US claimed
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US disclosed
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US disclosed
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 US disclosed
WO-2008101247-A2 6 ' SUBSTITUTED INDOLE AND INDAZOLE DERIVATIVES HAVING 5-HT6 RECEPTOR AFFINITY MEMORY PHARMACEUTICALS CORPORATION (US) 2008-08-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080200471-A1 6' SUBSTITUTED COMPOUNDS HAVING 5-HT6 RECEPTOR AFFINITY HTR6, HTR1B, HTR1A USP9X 3887/4885HTR6 1/4885HTR1A 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.